UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 586

Sortiert nach

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

Neurology, 2009-12, Vol.73 (22), p.1914

2009

Volltextzugriff (PDF)

Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment

Multiple sclerosis, 2018-04, Vol.24 (4), p.472-480

2018

Volltextzugriff (PDF)

Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis

Multiple sclerosis, 2014-04, Vol.20 (4), p.412-417

2014

Volltextzugriff (PDF)

A neurologist's perspective on serum neurofilament light in the memory clinic: a prospective implementation study

Alzheimer's research & therapy, 2021-05, Vol.13 (1), p.101-101, Article 101

2021

Volltextzugriff (PDF)

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

Neurology, 2009-04, Vol.72 (15), p.1322

2009

Volltextzugriff (PDF)

NFL and GFAP in (pre)symptomatic RVCL-S carriers: a monogenic cerebral small vessel disease

Journal of neurology, 2024-07, Vol.271 (7), p.4138-4145

2024

Volltextzugriff (PDF)

Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort

Neurology, 2012-01, Vol.78 (1), p.47

2012

Volltextzugriff (PDF)

CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome

Multiple sclerosis, 2013-04, Vol.19 (4), p.436-442

2013

Volltextzugriff (PDF)

Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies

Alzheimer's research & therapy, 2020-04, Vol.12 (1), p.44-44, Article 44

2020

Volltextzugriff (PDF)

Characterization of symptoms and determinants of disease burden in dementia with Lewy bodies: DEvELOP design and baseline results

Alzheimer's research & therapy, 2021-02, Vol.13 (1), p.53-53, Article 53

2021

Volltextzugriff (PDF)

Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency

Neurology, 2010-11, Vol.75 (18), p.1617

2010

Volltextzugriff (PDF)

Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients

Multiple sclerosis journal - experimental, translational and clinical, 2021-04, Vol.7 (2), p.20552173211013831-20552173211013831

2021

Volltextzugriff (PDF)

Antioxidants and polyunsaturated fatty acids in multiple sclerosis

European journal of clinical nutrition, 2005-12, Vol.59 (12), p.1347-1361

2005

Volltextzugriff (PDF)

Biochemical markers related to Alzheimer’s dementia in serum and cerebrospinal fluid

Neurobiology of aging, 2002, Vol.23 (4), p.485-508

2002

Volltextzugriff (PDF)

Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry

Multiple sclerosis, 2011-07, Vol.17 (7), p.838-850

2011

Volltextzugriff (PDF)

Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression

Multiple sclerosis, 2012-08, Vol.18 (8), p.1092-1098

2012

Volltextzugriff (PDF)

Inflammation markers in relation to cognition in a healthy aging population

Journal of neuroimmunology, 2003, Vol.134 (1), p.142-150

2003

Volltextzugriff (PDF)

Brain endothelial cell expression of SPARCL‐1 is specific to chronic multiple sclerosis lesions and is regulated by inflammatory mediators in vitro

Neuropathology and applied neurobiology, 2018-06, Vol.44 (4), p.404-416

2018

Volltextzugriff (PDF)

Brain-specific fatty acid-binding protein is elevated in serum of patients with dementia-related diseases

European journal of neurology, 2011-06, Vol.18 (6), p.865-871

2011

Volltextzugriff (PDF)

Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients

Neuroscience letters, 2003-08, Vol.347 (3), p.159-162

2003

Volltextzugriff (PDF)

Serum homocysteine levels in relation to clinical progression in multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2008-12, Vol.79 (12), p.1349-1353

2008

Volltextzugriff (PDF)

BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells

Cellular and molecular life sciences : CMLS, 2015-04, Vol.72 (8), p.1599-1611

2015

Volltextzugriff (PDF)

Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics

Brain (London, England : 1878), 2020-12, Vol.143 (12), p.3776-3792

2020

Volltextzugriff (PDF)

Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy

Multiple sclerosis, 2015-04, Vol.21 (4), p.481-484

2015

Volltextzugriff (PDF)

Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2009-10, Vol.80 (10), p.1110-1115

2009

Volltextzugriff (PDF)

1 – 25 von 586

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(571)
Mit Volltextzugriff
(500)

Publikationsform

Artikel
(570)
Tagungsberichte
(16)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment

Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis

A neurologist's perspective on serum neurofilament light in the memory clinic: a prospective implementation study

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis

NFL and GFAP in (pre)symptomatic RVCL-S carriers: a monogenic cerebral small vessel disease

Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort

CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome

Sex-specific associations with cerebrospinal fluid biomarkers in dementia with Lewy bodies

Characterization of symptoms and determinants of disease burden in dementia with Lewy bodies: DEvELOP design and baseline results

Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency

Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients

Antioxidants and polyunsaturated fatty acids in multiple sclerosis

Biochemical markers related to Alzheimer’s dementia in serum and cerebrospinal fluid

Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry

Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression

Inflammation markers in relation to cognition in a healthy aging population

Brain endothelial cell expression of SPARCL‐1 is specific to chronic multiple sclerosis lesions and is regulated by inflammatory mediators in vitro

Brain-specific fatty acid-binding protein is elevated in serum of patients with dementia-related diseases

Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients

Serum homocysteine levels in relation to clinical progression in multiple sclerosis

BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells

Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics

Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy

Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis

Suchergebnisse filtern